Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing...

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• The oncoprotein E6 from high-risk human papillomavirus (HPV) types drives cell proliferation and cervical cancer development.
• Understanding E6's role is crucial for developing targeted cervical cancer therapies.

Purpose of the Study:

• To investigate the effects of silencing the HPV-18 E6 gene using small interfering RNA (siRNA) in HeLa cells.
• To identify molecular pathways and gene expression changes induced by E6 knockdown.

Main Methods:

• Utilized siRNA technology to silence the HPV-18 E6 gene in HeLa cervical cancer cells.
• Employed microarray-based gene expression profiling to analyze global gene expression changes.
• Applied bioinformatics for functional classification of differentially expressed genes.

Main Results:

• siRNA effectively inhibited HPV-18 E6 gene expression and induced apoptosis in HeLa cells.
• Microarray analysis revealed 359 differentially expressed genes (307 up-regulated, 52 down-regulated).
• Key affected pathways included cell cycle, apoptosis, ubiquitin proteolysis, and keratinocyte differentiation.

Conclusions:

• HPV-18 E6 siRNA-induced apoptosis is mediated by the P53 and ubiquitin proteolysis pathways.
• E6 inhibition down-regulates proliferation and promotes apoptosis, reducing tumor cell malignancy.
• This approach provides insights into E6 oncogene function and potential therapeutic targets for cervical cancer.